UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
2014, ISBN 9789241548694, 58
eBook
Advances in anatomic pathology, ISSN 1072-4109, 01/2006, Volume 13, Issue 1, pp. 8 - 15
Immunohistochemistry | Diagnosis | Gynecologic neoplasms | p16 | Life Sciences & Biomedicine | Pathology | Science & Technology | Carcinoma, Small Cell - genetics | Humans | Cystadenocarcinoma, Serous - genetics | Genital Neoplasms, Female - diagnosis | Ovarian Neoplasms - genetics | Carcinoma, Small Cell - chemistry | Cystadenocarcinoma, Serous - chemistry | Cyclin-Dependent Kinase Inhibitor p16 - analysis | Endometrial Neoplasms - genetics | Tumor Suppressor Proteins - genetics | Female | Vulvar Neoplasms - diagnosis | Adenocarcinoma - genetics | Uterine Neoplasms - diagnosis | Adenocarcinoma - chemistry | Genital Neoplasms, Female - genetics | Genitalia, Female - chemistry | Uterine Neoplasms - chemistry | Uterine Neoplasms - genetics | Vulvar Neoplasms - classification | Diagnosis, Differential | Ovarian Neoplasms - chemistry | Uterine Cervical Neoplasms - diagnosis | Endometrial Neoplasms - chemistry | Biomarkers, Tumor - analysis | Ovarian Neoplasms - diagnosis | Genital Neoplasms, Female - chemistry | Endometrial Neoplasms - diagnosis | Uterine Cervical Neoplasms - genetics | Genes, p16 | Carcinoma, Small Cell - diagnosis | Genitalia, Female - physiopathology | Adenocarcinoma - diagnosis | Vulvar Neoplasms - genetics | Biomarkers, Tumor - genetics | Uterine Cervical Neoplasms - chemistry | Cystadenocarcinoma, Serous - diagnosis | Tumor Suppressor Proteins - analysis | Vulvar Neoplasms - chemistry | Index Medicus
Journal Article
Annals of oncology, ISSN 0923-7534, 12/2003, Volume 14, Issue 5, pp. v61 - v118
international comparison | Europe | population-based cancer registries | age-standardised relative survival | cancer survival | Cancer survival | Population-based cancer registries | Age-standardised relative survival | International comparison | Life Sciences & Biomedicine | Oncology | Science & Technology | Urologic Neoplasms - epidemiology | Testicular Neoplasms - mortality | Digestive System Neoplasms - mortality | Lung Neoplasms - mortality | Hematologic Neoplasms - mortality | Humans | Thyroid Neoplasms - epidemiology | Male | Neoplasms - diagnosis | Testicular Neoplasms - epidemiology | Hematologic Neoplasms - epidemiology | Genital Neoplasms, Female - epidemiology | Registries - statistics & numerical data | Skin Neoplasms - mortality | Head and Neck Neoplasms - epidemiology | Female | Brain Neoplasms - mortality | Breast Neoplasms - epidemiology | Digestive System Neoplasms - epidemiology | Thyroid Neoplasms - mortality | Urologic Neoplasms - mortality | Europe - epidemiology | Neoplasms - mortality | Survival Rate | Skin Neoplasms - epidemiology | Prostatic Neoplasms - mortality | Prostatic Neoplasms - epidemiology | Genital Neoplasms, Female - mortality | Lung Neoplasms - epidemiology | Sex Factors | Survival Analysis | Breast Neoplasms - mortality | Head and Neck Neoplasms - mortality | Neoplasms - epidemiology | Brain Neoplasms - epidemiology | Index Medicus
Journal Article
Gynecologic oncology, ISSN 0090-8258, 2016, Volume 144, Issue 1, pp. 11 - 15
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | Humans | Endometrial Neoplasms - metabolism | Neoplasms, Glandular and Epithelial - metabolism | Gynecologic Surgical Procedures | Cytoreduction Surgical Procedures | Peritoneal Neoplasms - diagnosis | Genital Neoplasms, Female - diagnosis | Vulvar Neoplasms - therapy | Societies, Medical | Uterine Cervical Neoplasms - metabolism | Vulvar Neoplasms - metabolism | Biomarkers, Tumor - metabolism | Female | Vulvar Neoplasms - diagnosis | Ovarian Neoplasms - metabolism | Neoplasms, Glandular and Epithelial - diagnosis | Uterine Cervical Neoplasms - therapy | Uterine Cervical Neoplasms - diagnosis | Ovarian Neoplasms - diagnosis | Gynecology | Neoplasms, Glandular and Epithelial - therapy | Endometrial Neoplasms - diagnosis | Survivorship | Poly(ADP-ribose) Polymerase Inhibitors - therapeutic use | Genital Neoplasms, Female - metabolism | Medical Oncology | Fallopian Tube Neoplasms - diagnosis | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Genital Neoplasms, Female - therapy | Peritoneal Neoplasms - metabolism | Carcinoma, Ovarian Epithelial | Endometrial Neoplasms - therapy | Ovarian Neoplasms - therapy | Fallopian Tube Neoplasms - metabolism | Peritoneal Neoplasms - therapy | Surgical Oncology | Fallopian Tube Neoplasms - therapy | Index Medicus
Journal Article
American journal of obstetrics and gynecology, ISSN 0002-9378, 02/2021, Volume 224, Issue 2, pp. 195.e1 - 195.e17
vaginal cancer | epidemiology | health disparities | ovarian cancer | quasi-experimental methods | uterine cancer | vulvar cancer | Affordable Care Act | cervical cancer | Uterine Neoplasms - therapy | Residence Characteristics | United States | Uterine Neoplasms - pathology | Humans | Middle Aged | Hispanic Americans | Ovarian Neoplasms - pathology | African Americans | Uterine Cervical Neoplasms - pathology | Educational Status | Medicaid - statistics & numerical data | Medicaid - legislation & jurisprudence | Genital Neoplasms, Female - diagnosis | Patient Protection and Affordable Care Act - legislation & jurisprudence | Vulvar Neoplasms - pathology | Vulvar Neoplasms - therapy | Non-Randomized Controlled Trials as Topic | Adult | Female | Vulvar Neoplasms - diagnosis | Retrospective Studies | Uterine Neoplasms - diagnosis | Vaginal Neoplasms - therapy | Health Policy | Uterine Cervical Neoplasms - therapy | Ethnic Groups - statistics & numerical data | Time-to-Treatment - statistics & numerical data | Poverty | Uterine Cervical Neoplasms - diagnosis | Early Detection of Cancer | Ovarian Neoplasms - diagnosis | Vaginal Neoplasms - pathology | European Continental Ancestry Group | Propensity Score | Medically Uninsured - statistics & numerical data | Genital Neoplasms, Female - therapy | Ovarian Neoplasms - therapy | Neoplasm Staging | Genital Neoplasms, Female - pathology | Vaginal Neoplasms - diagnosis | Cohort Studies | Women | Medicaid | Analysis | Index Medicus | Abridged Index Medicus
Journal Article
The American journal of surgical pathology, ISSN 0147-5185, 02/2014, Volume 38, Issue 2, pp. 176 - 188
perivascular epithelioid cell | gynecologic | PEComa | Pathology | Life Sciences & Biomedicine | Surgery | Science & Technology | Immunohistochemistry | Predictive Value of Tests | Humans | Middle Aged | Genital Neoplasms, Female - diagnosis | Perivascular Epithelioid Cell Neoplasms - therapy | Time Factors | Adult | Female | Retrospective Studies | Perivascular Epithelioid Cell Neoplasms - chemistry | Genital Neoplasms, Female - genetics | Diagnosis, Differential | Biomarkers, Tumor - analysis | Genital Neoplasms, Female - chemistry | In Situ Hybridization, Fluorescence | Treatment Outcome | Tumor Burden | Perivascular Epithelioid Cell Neoplasms - secondary | Genital Neoplasms, Female - mortality | Perivascular Epithelioid Cell Neoplasms - genetics | Genital Neoplasms, Female - therapy | Biomarkers, Tumor - genetics | Perivascular Epithelioid Cell Neoplasms - diagnosis | Genital Neoplasms, Female - pathology | Perivascular Epithelioid Cell Neoplasms - mortality | Index Medicus
Journal Article
Clinical chemistry and laboratory medicine, ISSN 1434-6621, 08/2018, Volume 56, Issue 9, pp. 1413 - 1425
molecular mechanisms | gynecological cancer | type 2 diabetes | Life Sciences & Biomedicine | Medical Laboratory Technology | Science & Technology | Hypoglycemic Agents - therapeutic use | Uterine Cervical Neoplasms - diagnosis | Ovarian Neoplasms - diagnosis | Humans | Uterine Cervical Neoplasms - epidemiology | Insulin Resistance | Genital Neoplasms, Female - complications | Endometrial Neoplasms - epidemiology | Endometrial Neoplasms - diagnosis | Genital Neoplasms, Female - epidemiology | Ovarian Neoplasms - complications | Ovarian Neoplasms - epidemiology | Genital Neoplasms, Female - diagnosis | Diabetes Mellitus, Type 2 - diagnosis | Vulvar Neoplasms - complications | Uterine Cervical Neoplasms - complications | Endometrial Neoplasms - complications | Vulvar Neoplasms - epidemiology | Female | Vulvar Neoplasms - diagnosis | Diabetes Mellitus, Type 2 - drug therapy | Diabetes Mellitus, Type 2 - complications | Type 2 diabetes | Complications and side effects | Risk factors | Genital diseases, Female | Ovarian carcinoma | Mortality | Diabetes mellitus | Health risks | Risk | Hormones | Cervix | Insulin | Epidemiology | Neoplasms | Ovarian cancer | Diagnostic systems | Diabetes | Metformin | Health risk assessment | Diabetes mellitus (non-insulin dependent) | Steroid hormones | Endometrium | Cervical cancer | Cancer | Index Medicus
Journal Article
American journal of obstetrics and gynecology, ISSN 0002-9378, 2011, Volume 204, Issue 6, pp. 466 - 478
Obstetrics and Gynecology | cytology | ovarian cancer | endometrial cancer | gynecologic cancer | surveillance | cervical cancer | imaging | Life Sciences & Biomedicine | Obstetrics & Gynecology | Science & Technology | Gynecology. Andrology. Obstetrics | Biological and medical sciences | Medical sciences | Female genital diseases | Tumors | Uterine Cervical Neoplasms - diagnosis | Ovarian Neoplasms - diagnosis | Humans | Neoplasm Recurrence, Local - diagnosis | Endometrial Neoplasms - diagnosis | Genital Neoplasms, Female - diagnosis | Genital Neoplasms, Female - therapy | Checklist | Endometrial Neoplasms - therapy | Ovarian Neoplasms - therapy | Female | Population Surveillance | Uterine Cervical Neoplasms - therapy | Women | Medical colleges | Care and treatment | Endometrial cancer | Oncology, Experimental | Diagnosis | Research | Cervical cancer | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
The American journal of surgical pathology, ISSN 0147-5185, 03/2015, Volume 39, Issue 3, pp. 394 - 404
gynecologic | PEComa | clear cell | TFE3 | Pathology | Life Sciences & Biomedicine | Surgery | Science & Technology | Immunohistochemistry | Predictive Value of Tests | Translocation, Genetic | United States | Humans | Middle Aged | Perivascular Epithelioid Cell Neoplasms - therapy | Time Factors | Female | Perivascular Epithelioid Cell Neoplasms - chemistry | Genital Neoplasms, Female - genetics | Diagnosis, Differential | Genetic Predisposition to Disease | Biomarkers, Tumor - analysis | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors - analysis | Genital Neoplasms, Female - chemistry | In Situ Hybridization, Fluorescence | Treatment Outcome | Perivascular Epithelioid Cell Neoplasms - secondary | Perivascular Epithelioid Cell Neoplasms - genetics | Genital Neoplasms, Female - therapy | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors - genetics | Aged | Biomarkers, Tumor - genetics | Genital Neoplasms, Female - pathology | Index Medicus
Journal Article